311 related articles for article (PubMed ID: 27665357)
61. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.
Bhasin S; Travison TG; Pencina KM; O'Leary M; Cunningham GR; Lincoff AM; Nissen SE; Lucia MS; Preston MA; Khera M; Khan N; Snabes MC; Li X; Tangen CM; Buhr KA; Thompson IM
JAMA Netw Open; 2023 Dec; 6(12):e2348692. PubMed ID: 38150256
[TBL] [Abstract][Full Text] [Related]
62. Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Barbera M; Panella P; Pennisi M; Morgia G
Arch Ital Urol Androl; 2016 Dec; 88(4):300-303. PubMed ID: 28073197
[TBL] [Abstract][Full Text] [Related]
63. Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?
Felker ER; Raman SS; Margolis DJ; Lu DSK; Shaheen N; Natarajan S; Sharma D; Huang J; Dorey F; Marks LS
AJR Am J Roentgenol; 2017 Dec; 209(6):1272-1277. PubMed ID: 28858541
[TBL] [Abstract][Full Text] [Related]
64. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
García-Cruz E; Piqueras M; Huguet J; Peri L; Izquierdo L; Musquera M; Franco A; Alvarez-Vijande R; Ribal MJ; Alcaraz A
BJU Int; 2012 Dec; 110(11 Pt B):E541-6. PubMed ID: 22584031
[TBL] [Abstract][Full Text] [Related]
65. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
66. Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting.
Grey AD; Chana MS; Popert R; Wolfe K; Liyanage SH; Acher PL
BJU Int; 2015 May; 115(5):728-35. PubMed ID: 25041307
[TBL] [Abstract][Full Text] [Related]
67. Changes in Gleason score grading on serial follow-up biopsies in prostate cancer patients undergoing active surveillance.
Guijarro A; Hernández V; López B; Capitán C; Pérez-Fernández E; de la Peña E; de la Morena JM; Llorente C
Actas Urol Esp; 2015 Apr; 39(3):139-43. PubMed ID: 25305107
[TBL] [Abstract][Full Text] [Related]
68. Development and External Validation of Multiparametric MRI-Derived Nomogram to Predict Risk of Pathologic Upgrade in Patients on Active Surveillance for Prostate Cancer.
Kim SH
AJR Am J Roentgenol; 2020 Apr; 214(4):825-834. PubMed ID: 31913073
[No Abstract] [Full Text] [Related]
69. Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.
Shaw GL; Thomas BC; Dawson SN; Srivastava G; Vowler SL; Gnanapragasam VJ; Shah NC; Warren AY; Neal DE
Br J Cancer; 2014 May; 110(10):2405-11. PubMed ID: 24722183
[TBL] [Abstract][Full Text] [Related]
70. Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients.
Iremashvili V; Manoharan M; Lokeshwar SD; Rosenberg DL; Pan D; Soloway MS
BJU Int; 2013 Mar; 111(3):396-403. PubMed ID: 22703025
[TBL] [Abstract][Full Text] [Related]
71. The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism.
Efesoy O; Apa D; Tek M; Çayan S
Aging Male; 2016 Jun; 19(2):79-84. PubMed ID: 26927833
[TBL] [Abstract][Full Text] [Related]
72. Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score.
Porpiglia F; DE Luca S; Passera R; Manfredi M; Mele F; Bollito E; DE Pascale A; Cossu M; Aimar R; Veltri A
Anticancer Res; 2016 Sep; 36(9):4833-9. PubMed ID: 27630337
[TBL] [Abstract][Full Text] [Related]
73. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
[TBL] [Abstract][Full Text] [Related]
74. Multiparametric Magnetic Resonance Imaging-based Prostate Specific Antigen Density and PI-RADSv2 score help identify Apical Prostate Cancer.
Huang C; Rui R; Feng N; He Q; Gong Y; Li X; He S; Zhou L
J Cancer; 2023; 14(8):1371-1380. PubMed ID: 37283788
[No Abstract] [Full Text] [Related]
75. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
76. Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active Surveillance.
Anderson CB; Sternberg IA; Karen-Paz G; Kim PH; Sjoberg D; Vargas HA; Touijer K; Eastham JA; Ehdaie B
J Urol; 2015 Dec; 194(6):1607-11. PubMed ID: 26119671
[TBL] [Abstract][Full Text] [Related]
77. The role of MRI in active surveillance for men with localized prostate cancer.
Recabal P; Ehdaie B
Curr Opin Urol; 2015 Nov; 25(6):504-9. PubMed ID: 26372037
[TBL] [Abstract][Full Text] [Related]
78. Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance.
O'Connor LP; Wang AZ; Yerram NK; Long L; Ahdoot M; Lebastchi AH; Gurram S; Zeng J; Harmon SA; Mehralivand S; Merino MJ; Parnes HL; Choyke PL; Shih JH; Wood BJ; Turkbey B; Pinto PA
Eur Urol Oncol; 2021 Apr; 4(2):227-234. PubMed ID: 33867045
[TBL] [Abstract][Full Text] [Related]
79. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.
Cary KC; Cowan JE; Sanford M; Shinohara K; Perez N; Chan JM; Meng MV; Carroll PR
Eur Urol; 2014 Aug; 66(2):337-42. PubMed ID: 24035632
[TBL] [Abstract][Full Text] [Related]
80. Repeat multiparametric MRI in prostate cancer patients on active surveillance.
Eineluoto JT; Järvinen P; Kenttämies A; Kilpeläinen TP; Vasarainen H; Sandeman K; Erickson A; Mirtti T; Rannikko A
PLoS One; 2017; 12(12):e0189272. PubMed ID: 29281647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
